Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Alexander Ingram Other companies: Black Diamond Therapeutics, Inc. (Director · Sep 25, 2020 – Sep 16, 2022 · Past); Novan Inc (Director · Sep 20, 2016 – Jul 28, 2020 · Past); BioCryst Pharmaceuticals, Inc. (Director · Aug 5, 2015 – Feb 28, 2023 · Past); Pharmaceutical Product Development Inc (Director · May 18, 2011 – Dec 5, 2011 · Past); Bausch Health Companies Inc. (Director · Sep 28, 2010 – Mar 31, 2017 · Past); Wolfspeed, Inc. (Director · Dec 29, 2008 – Oct 17, 2018 · Past); Edwards Lifesciences Corporation (Director · May 12, 2006 – May 15, 2015 · Past); Osi Pharmaceuticals Inc (Director · Mar 16, 2006 – Jun 8, 2010 · Past); Valeant Pharmaceuticals International Inc (Director · Jan 1, 2006 – Sep 28, 2010 · Past); Lowe's Companies, Inc. (Director · Dec 31, 2005 – Mar 31, 2011 · Past); Nortel Networks Corporation (USA) (Director · Dec 30, 2005 – Mar 31, 2006 · Past) | Director · Apr 4, 2014 – May 22, 2015 · Past |
| David Schenkein Other companies: Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Denali Therapeutics Inc. (Director · Since at least Dec 7, 2017); Foundation Medicine Inc (Director · Sep 24, 2013 – Jun 16, 2016 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Jun 20, 2024 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Jun 18, 2020 · Past); Foghorn Therapeutics Inc. (General Partner, Co-leader, Agios · Until Apr 13, 2026 · Past) | Director · Since at least Sep 8, 2023 |
| Christine A. Poon Other companies: Neurocrine Biosciences, Inc. (Director · Since at least Jul 11, 2023); Prudential Financial, Inc. (Director · Since at least Sep 1, 2006); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Feb 11, 2021 · Past); Sherwin-Williams Company (the) (Director · Apr 16, 2014 – Apr 4, 2025 · Past); Johnson & Johnson (Vice Chairman, Director · Dec 30, 2005 – Feb 12, 2009 · Past) | Director · Since at least Nov 12, 2010 |
| Arthur F Ryan Other companies: Citizens Financial Group, Inc. (Director · Sep 23, 2014 – Feb 14, 2019 · Past); JetPay Corporation (Director · May 9, 2011 – Dec 28, 2012 · Past); Prudential Financial, Inc. (Chairman, Director · Feb 14, 2006 – Feb 12, 2008 · Past) | Director · Since at least Jan 3, 2006 |
| Bonnie Bassler Other companies: Cidara Therapeutics Inc (Director · Since at least Jan 22, 2021); Royalty Pharma plc (Board Member · Since at least Jun 15, 2020); Kaleido Biosciences, Inc. (Director · Feb 27, 2019 – Jun 30, 2021 · Past) | Chair, Department of Molecular Biology, and Squibb Professor in Molecular Biology, Princeton University · Since at least Sep 9, 2016 |
| Murray A Goldberg Other companies: Ayala Pharmaceuticals Inc (Director · May 7, 2020 – Jan 19, 2023 · Past); Teva Pharmaceutical Industries Limited (Director · Jan 1, 2018 – Jun 11, 2019 · Past); Aerie Pharmaceuticals Inc. (Director · Oct 25, 2013 – May 18, 2020 · Past) | SVP Administration & Asst Secr · Jan 9, 2006 – Dec 16, 2014 · Past |
| Robert E. Landry Other companies: Theravance Biopharma, Inc. (Director · Since at least Nov 5, 2026); Zymeworks Inc. (Director · Since at least Aug 10, 2025); Cytokinetics, Incorporated (Director · Since at least Feb 10, 2025) | EVP Finance CFO · Mar 31, 2022 – Feb 2, 2024 · Past |
| Tony Coles Other companies: Kineta Inc. (Executive Chair, Director · Dec 22, 2020 – Apr 1, 2021 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); McKesson Corporation (Director · Jul 25, 2018 – Aug 17, 2020 · Past) | Director · Since at least Jan 2, 2018 |
| Craig B Thompson Other companies: Charles River Laboratories International, Inc. (Director · Since at least Dec 3, 2013); Merck & Company, Inc. (Director · Dec 1, 2008 – May 25, 2018 · Past) | Director · Since at least Oct 3, 2022 |
| Charles A Baker Other companies: Progenics Pharmaceuticals Inc (Director · Jul 3, 2006 – Jun 13, 2012 · Past) | Director · Jan 3, 2006 – Jan 2, 2018 · Past |
| Marc Tessier-Lavigne Other companies: Denali Therapeutics Inc. (Director · Since at least May 30, 2019) | Director · Jan 2, 2020 – Jan 3, 2023 · Past |
| Michael S. Brown Other companies: Pfizer, Inc. (Director · Apr 27, 2006 – Apr 28, 2011 · Past) | Distinguished Chair in Biomedical Sciences, Regental Professor of Molecular Genetics and Internal Medicine, and Director, Erik Jonsson Center for Molecular Genetics, The University of Texas Southweste · Since at least Jan 3, 2006 |
| Alexandra Bowie | Regeneron Investor Relations · Since at least Oct 1, 2026 |
| Andrew Murphy | Executive Vice President, Research and Co-Chief Scientific Officer · Since at least Dec 11, 2019 |
| Benjamin Yocum | Senior Vice President, Manufacturing Operations · Since at least Nov 4, 2026 |
| Brook Jennings | Senior Vice President, Global Immunology Commercial Business Unit · Since at least Nov 4, 2026 |
| Chris Fenimore | Executive Vice President, Finance and Chief Financial Officer · Since at least Nov 4, 2026 |
| Christina Chan | Corporate Communications · Since at least Sep 24, 2026 |
| Christopher R Fenimore | EVP Finance CFO · Since at least Mar 2, 2017 |
| Daniel Van Plew | Executive Vice President and General Manager, Industrial Operations and Product Supply · Since at least Sep 7, 2007 |
| Danilo Verge | Senior Vice President, Global Medical Affairs · Since at least Nov 4, 2026 |
| David Snow | Director · Since at least Feb 23, 2026 |
| Diana Hughes | Senior Vice President, Global Patient Safety · Since at least Nov 4, 2026 |
| Divya Pathak | Senior Vice President, Chief Artificial Intelligence Officer · Since at least Nov 4, 2026 |
| Eric M Shooter | Director · Jan 2, 2009 – Feb 12, 2014 · Past |
| George D. Yancopoulos | Board co-Chair, President and Chief Scientific Officer · Since at least Oct 30, 2015 |
| George Fraley | Senior Vice President, Associate General Counsel · Since at least Nov 4, 2026 |
| George L Sing | Director · Since at least Jan 3, 2006 |
| Huda Y Zoghbi | Director · Since at least Jan 2, 2020 |
| Ilana Yellen | Regeneron Investor Relations · Since at least Feb 27, 2026 |
| Jason Pitofsky | SVP Controller · Since at least Feb 6, 2024 |
| John Calabro | Senior Vice President, Internal Audit · Since at least Nov 4, 2026 |
| Joseph J. LaRosa | Executive Vice President, General Counsel and Secretary · Since at least Dec 16, 2011 |
| Joseph L. Goldstein | Professor of Molecular Genetics and Internal Medicine and Chair, Department of Molecular Genetics, The University of Texas Southwestern Center at Dallas · Since at least Mar 30, 2022 |
| Justin Holko | Senior Vice President, Global Oncology/Hematology Commercial Business Unit · Since at least Nov 4, 2026 |
| Kailey Kilmartin | Regeneron Investor Relations · Since at least Mar 24, 2026 |
| Kathryn Guarini | Director · Since at least Sep 8, 2023 |
| Kerry Reinertsen | Senior Vice President, Strategic Alliances · Since at least Nov 4, 2026 |
| Kevin Clark | Senior Vice President, Global Ophthalmology Commercial Business Unit · Since at least Nov 4, 2026 |
| L. Andres Sirulnik | Senior Vice President, Clinical Development Unit Head, Hematology · Since at least Nov 13, 2025 |
| Larry Coury | Senior Vice President, Associate General Counsel · Since at least Nov 4, 2026 |
| Leonard S. Schleifer | Board co-Chair, President and Chief Executive Officer · Since at least Mar 6, 2006 |
| Mack MacKenzie | Senior Vice President, Commercial and G&A Digital & Technology · Since at least Nov 4, 2026 |
| Marion McCourt | Executive Vice President, Commercial · Since at least Apr 1, 2022 |
| Mark Hudson | Investor Relations · Since at least Oct 25, 2026 |
| Matthew Everett | Senior Vice President, Global Procurement · Since at least Nov 4, 2026 |
| Melissa Lozner | Senior Vice President, Chief Compliance Officer · Since at least Nov 4, 2026 |
| Ned Braunstein | Executive Vice President, Regulatory Affairs, Global Patient Safety & Development Quality · Since at least Nov 4, 2026 |
| Neil Stahl | EVP Research and Development · Dec 9, 2020 – Dec 16, 2024 · Past |
| Peter Dworkin | VP Investor Relations & Commun · Apr 3, 2009 – Dec 18, 2009 · Past |
| P Roy Vagelos | Director · Mar 30, 2022 – Apr 3, 2023 · Past |
| Richard Gluckselig | Senior Vice President, Associate General Counsel & Assistant Secretary · Since at least Nov 4, 2026 |
| Rick Hall | Senior Vice President, Human Resources and Chief Human Resources Officer · Since at least Nov 4, 2026 |
| Ryan Crowe | Senior Vice President, Investor Relations & Strategic Analysis · Since at least Nov 2, 2026 |
| Ryan Steinberger | Executive Vice President, Chief Digital & Technology Officer · Since at least Nov 5, 2026 |
| Sharon Chen | Regeneron Investor Relations · Since at least Dec 23, 2025 |
| Zoran Berkovic | Senior Vice President, Financial Planning and Analysis · Since at least Nov 4, 2026 |